Treatment of a unique anemia in patients with IDDM with epoetin alfa

Diabetes Care

Volumn 21, Issue 3, 1998, Pages 423-426

  Rarick, Mark U ^a,c   Espina, Byron M ^b   Colley, Daniel T ^b   Chrusoskie, Aaron ^a   Gandara, Shannan ^a   Feinstein, Donald I ^b  

^a Division of Pediatric Hematology Oncology   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DOSE RESPONSE; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

AGED; AGED, 80 AND OVER; ANEMIA; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOETIN ALFA; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMATOCRIT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POTASSIUM; TREATMENT OUTCOME;

EID: 0031912682     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.3.423     Document Type: Article

References (15)

1. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of longer term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW: Treatment of the anemia or progressive renal failure with recombinant human erythropoietin. N Engl J Med 321:158-163, 1989
3. Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry R, Fangman J: Recombinant human erythropoietin treatment in pre-dialysis patients. Ann Intern Med 110:108-114, 1989
4. Schuster S, Wilson J, Erslev AJ, Caro J: Physiologic regulation and tissue localization of renal erythropoietin mRNA. Blood 70:316-318, 1987
5. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 317:693, 1989
6. Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS, Galpin JE, Groopman JE, Hooton TM, Jemsek JG, Levine RL, Miles SA, Rinehart JJ, Rios A, Robbins WJ, Ruckdeschel JC, Smith JA, Spruance SL, Starrett B, Toney J, Zalusky R, Abels RI, Bryant EC, Larholt KM, Sampson AR, Rudnick SA: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy: overview of four clinical trials. Ann Intern Med 117:739-748, 1992
7. Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, Salmon SE, Silver RT, Storniolo AM, Wampler GL, Dooley CM, Larholt KM, Nelson RA, Abels RI: Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst. 85:801-806, 1993
8. Spivak JL, Barnes DC, Fuch E, Quinn TC: Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261:3104-3107, 1989
9. Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill P, Bernstein-Singer M, Levine AM: Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J AIDS 4:593-597, 1991
10. Miller CB, Jones RJ, Piandosi S, Abeloff MD, Spivak JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692, 1990
11. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, Loch H, Raedler A: Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 334:619-623, 1996
12. Bauer JH, Brooks CS, Bunch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 2:337-346, 1982
13. Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM: Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal failure. Blood 54:877-884, 1979
14. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V: The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 121:181-186, 1994
15. Kojima K, Totsuka Y: Anemia due to reduced serum erythropoietin concentration in non-uremic diabetic patients. Diab Res Clin Prac 27:229-233, 1995